News

Ulta Beauty would like to put a couple of ugly quarters behind it. Wall Street still fancies the stock.

Bath & Body Works (BBWI) shares jumped Wednesday as the company raised its full-year earnings outloo

Organic sales returned to growth with margin expansion and strong earnings.

Estee Lauder's (EL) turnaround continues to progress and its fiscal 2027 guidance is achievable, RBC

Organic sales rose 5% in Q4, the best quarter of fiscal 2026, as the company delivered a 66% surge in diluted EPS and outlined a confident fiscal 2027 outlook.

Moby summary of The Estée Lauder Companies Inc.'s Q4 2026 earnings call

Estee Lauder (EL) shares rallied Wednesday after the cosmetics maker bumped up its fiscal 2027 opera

EL beats fiscal fourth-quarter estimates as sales rise 6%, fueled by Skin Care and Fragrance growth and sharply higher operating income.

On this episode of Stock Movers: - Shares of Moderna (MRNA) surged by a record 101% - the stock's biggest intraday gain on record - after the biotech said a personalized cancer vaccine combined with partner Merck & Co.'s Keytruda helped cut the recurrence of melanoma in a large, late-stage trial. The study also met a key secondary goal of showing the shot could help prevent tumors from spreading to new areas of the body, the companies said in a statement Wednesday. - Shares of Estee Lauder (EL) rallied after the beauty company's adjusted earnings per share and sales metrics topped consensus expectations for the fourth quarter. The midpoint of fiscal 2027 organic sales and adjusted EPS guidance ranges are above Street views. - Shares of La-Z-Boy (LZB) tumbled at the open after the furniture maker's forecast sales for the second quarter missed the average analyst estimate.

Estee Lauder Companies Inc (NYSE:EL, XETRA:ELAA) shares jumped more than 15% on Wednesday after the beauty group posted fourth-quarter results that beat Wall Street estimates and raised its profit margin outlook for fiscal 2027. The company reported revenue of $3.6 billion for its fiscal...

Estee Lauder Companies (NYSE:EL) said fiscal 2026 marked a return to growth and a substantial improvement in profitability as the prestige beauty company advanced its Beauty Reimagined strategy and Profit Recovery and Growth Plan. For the full fiscal year, reported sales rose 5% and organic sales i

Shares of Estée Lauder advanced on Wednesday as the beauty and cosmetics giant’s better-than-expected quarterly earnings showed Wall Street its growth plan is well underway. The company announced adjusted earnings of 39 cents a share in the fiscal fourth quarter, up from 9 cents a year ago and above Wall Street’s expectation of 32 cents. Estée Lauder reported adjusted earnings of $2.51 a share for the full fiscal year, up from $1.51 last year.

The cosmetics company forecast fiscal 2027 adjusted EPS of $3.10 to $3.35, with the midpoint above analyst estimates

Estee Lauder (EL) delivered earnings and revenue surprises of +21.88% and +2.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Retail earnings are set to offer a check of consumer health this week as the second quarter earnings season winds down.

Retail earnings are set to offer a check of consumer health this week as the second quarter earnings season winds down.

Retail earnings are set to offer a check of consumer health this week as the second quarter earnings season winds down.

Retail earnings are set to offer a check of consumer health this week as the second quarter earnings season winds down.

Beauty products company Estée Lauder (NYSE:EL) will be announcing earnings results this Wednesday before the bell. Here’s what to expect.

Estee Lauder (EL) is likely to provide full-year guidance in line with its preliminary expectations,

Nu Skin (NUS) delivered earnings and revenue surprises of 0.00% and -7.27%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

WPP PLC (WPP) reports sequential improvement in Q2, strong new business wins, and strategic investments in AI and high-growth areas despite ongoing client losses and margin pressures.

Estée Lauder is set to release its fourth-quarter results next month, and analysts expect its earnings per share to surge by triple digits from a year ago.

Market Catalysts host Julie Hyman takes a look at some of Friday's trending tickers and stories, including Deckers Outdoor's (DECK) fourth quarter sales, Workday (WDAY) stock rising on first quarter earnings, IMAX (IMAX) reportedly exploring a sale, and Estée Lauder (EL) stock surging after merger talks with Puig ended.

e.l.f. Beauty posts fiscal fourth quarter sales growth of 35.1% as Rhode boosts results, while margins face pressure from higher operating costs.